HomeCERS • NASDAQ
add
Cerus Corp
Previous close
$1.80
Day range
$1.77 - $1.84
Year range
$1.21 - $2.59
Market cap
329.83M USD
Avg Volume
800.74K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 45.08M | 16.02% |
Operating expense | 28.50M | -7.61% |
Net income | -5.78M | 56.50% |
Net profit margin | -12.81 | 62.51% |
Earnings per share | -0.03 | 51.38% |
EBITDA | -3.36M | 62.17% |
Effective tax rate | 0.96% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 71.19M | -15.75% |
Total assets | 185.50M | -6.72% |
Total liabilities | 135.20M | -8.14% |
Total equity | 50.30M | — |
Shares outstanding | 185.30M | — |
Price to book | 6.67 | — |
Return on assets | -5.12% | — |
Return on capital | -6.40% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -5.78M | 56.50% |
Cash from operations | 401.00K | 104.46% |
Cash from investing | -7.11M | -405.15% |
Cash from financing | -1.40M | -710.98% |
Net change in cash | -8.12M | -16.72% |
Free cash flow | -3.31M | 53.10% |
About
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry. Wikipedia
Founded
Sep 1991
Headquarters
Website
Employees
631